TRAX insider trading
NasdaqGS HealthcareFirst Tracks Biotherapeutics, Inc.: insider trade history from SEC Form 4 filings.
About First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
TRAX insider activity at a glance
FilingIQ tracks 11 insider transactions for TRAX in filings since Apr 22, 2026. The most recent transaction is dated Sep 15, 2026.
Across the full history, 0 open-market purchases
and 2 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TRAX insider trades is 65.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TRAX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for TRAX?
- FilingIQ tracks 11 Form 4 insider transactions for TRAX (First Tracks Biotherapeutics, Inc.), covering filings from Apr 22, 2026 onwards. 3 of those are dated within the last 90 days.
- Are TRAX insiders net buyers or net sellers?
- Across the full Form 4 history for TRAX, 0 transactions (0%) were open-market purchases and 2 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TRAX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is TRAX in?
- First Tracks Biotherapeutics, Inc. (TRAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $655.71M.
Methodology & sources
Every TRAX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.